Clinical Trial Update: A Study to Monitor Intragastric pH in Patients Taking Rabeprazole vs. Patients Taking Pantoprazole [Phase 1]

View source ↗

Summary

A Phase 1 study comparing intragastric pH in GERD patients treated with rabeprazole versus pantoprazole has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastroesophageal Reflux Disease

Drugs mentioned

• Pantoprazole (pantoprazole)
• Rabeprazole (rabeprazole)

Snippet

Sponsor: Janssen-Ortho Inc., Canada | Conditions: GERD | Phase 1 | Status: COMPLETED